[Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019].
Identifieur interne : 001320 ( Ncbi/Merge ); précédent : 001319; suivant : 001321[Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019].
Auteurs : Y H Li [République populaire de Chine] ; L. Shen ; J. LiSource :
- Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery [ 1671-0274 ] ; 2020.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
- complications : Colorectal Neoplasms, Coronavirus Infections, Pneumonia, Viral.
- drug therapy : Colorectal Neoplasms.
- Antineoplastic Combined Chemotherapy Protocols, Chemotherapy, Adjuvant, Disease Outbreaks, Humans.
Abstract
The outbreak of corona virus disease 2019 (COVID-19) makes the medical treatment of colorectal cancers difficult. Cancer patients are more susceptible to infection and tumor history is defined as an important factor of poor prognosis, which challenges both doctors and patients. For metastatic colorectal cancer (CRC) patients, maintenance therapy is the optimal choice. The patients with tumor progression or poor biological behavior should receive or continue combination chemotherapy. Adjuvant chemotherapy should reduce the intensity of treatment and shorten the therapy time. Fever patients during chemotherapy need to receive differential diagnosis and screening according to national standards. Patients with stable diseases and good general conditions may delay imaging examination. Clinicians should make individual clinical decisions based on the specifics of each patient during epidemic situation.
DOI: 10.3760/cma.j.cn.441530-20200225-00089
PubMed: 32192297
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000282
- to stream PubMed, to step Curation: 000282
- to stream PubMed, to step Checkpoint: 000107
Links to Exploration step
pubmed:32192297Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019].</title><author><name sortKey="Li, Y H" sort="Li, Y H" uniqKey="Li Y" first="Y H" last="Li">Y H Li</name><affiliation wicri:level="1"><nlm:affiliation>Department of Gastrointestinal Cancer, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Bejing 100142, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Gastrointestinal Cancer, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Bejing 100142</wicri:regionArea><wicri:noRegion>Bejing 100142</wicri:noRegion></affiliation></author><author><name sortKey="Shen, L" sort="Shen, L" uniqKey="Shen L" first="L" last="Shen">L. Shen</name></author><author><name sortKey="Li, J" sort="Li, J" uniqKey="Li J" first="J" last="Li">J. Li</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32192297</idno><idno type="pmid">32192297</idno><idno type="doi">10.3760/cma.j.cn.441530-20200225-00089</idno><idno type="wicri:Area/PubMed/Corpus">000282</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000282</idno><idno type="wicri:Area/PubMed/Curation">000282</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000282</idno><idno type="wicri:Area/PubMed/Checkpoint">000107</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000107</idno><idno type="wicri:Area/Ncbi/Merge">001320</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019].</title><author><name sortKey="Li, Y H" sort="Li, Y H" uniqKey="Li Y" first="Y H" last="Li">Y H Li</name><affiliation wicri:level="1"><nlm:affiliation>Department of Gastrointestinal Cancer, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Bejing 100142, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Gastrointestinal Cancer, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Bejing 100142</wicri:regionArea><wicri:noRegion>Bejing 100142</wicri:noRegion></affiliation></author><author><name sortKey="Shen, L" sort="Shen, L" uniqKey="Shen L" first="L" last="Shen">L. Shen</name></author><author><name sortKey="Li, J" sort="Li, J" uniqKey="Li J" first="J" last="Li">J. Li</name></author></analytic><series><title level="j">Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery</title><idno type="ISSN">1671-0274</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term><term>Chemotherapy, Adjuvant</term><term>Colorectal Neoplasms (complications)</term><term>Colorectal Neoplasms (drug therapy)</term><term>Coronavirus Infections (complications)</term><term>Disease Outbreaks</term><term>Humans</term><term>Pneumonia, Viral (complications)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Flambées de maladies</term><term>Humains</term><term>Infections à coronavirus ()</term><term>Pneumopathie virale ()</term><term>Protocoles de polychimiothérapie antinéoplasique</term><term>Traitement médicamenteux adjuvant</term><term>Tumeurs colorectales ()</term><term>Tumeurs colorectales (traitement médicamenteux)</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Colorectal Neoplasms</term><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Colorectal Neoplasms</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs colorectales</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term><term>Chemotherapy, Adjuvant</term><term>Disease Outbreaks</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Flambées de maladies</term><term>Humains</term><term>Infections à coronavirus</term><term>Pneumopathie virale</term><term>Protocoles de polychimiothérapie antinéoplasique</term><term>Traitement médicamenteux adjuvant</term><term>Tumeurs colorectales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The outbreak of corona virus disease 2019 (COVID-19) makes the medical treatment of colorectal cancers difficult. Cancer patients are more susceptible to infection and tumor history is defined as an important factor of poor prognosis, which challenges both doctors and patients. For metastatic colorectal cancer (CRC) patients, maintenance therapy is the optimal choice. The patients with tumor progression or poor biological behavior should receive or continue combination chemotherapy. Adjuvant chemotherapy should reduce the intensity of treatment and shorten the therapy time. Fever patients during chemotherapy need to receive differential diagnosis and screening according to national standards. Patients with stable diseases and good general conditions may delay imaging examination. Clinicians should make individual clinical decisions based on the specifics of each patient during epidemic situation.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">32192297</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>23</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1671-0274</ISSN><JournalIssue CitedMedium="Print"><Volume>23</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>25</Day></PubDate></JournalIssue><Title>Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery</Title><ISOAbbreviation>Zhonghua Wei Chang Wai Ke Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019].</ArticleTitle><Pagination><MedlinePgn>217-219</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.cn.441530-20200225-00089</ELocationID><Abstract><AbstractText>The outbreak of corona virus disease 2019 (COVID-19) makes the medical treatment of colorectal cancers difficult. Cancer patients are more susceptible to infection and tumor history is defined as an important factor of poor prognosis, which challenges both doctors and patients. For metastatic colorectal cancer (CRC) patients, maintenance therapy is the optimal choice. The patients with tumor progression or poor biological behavior should receive or continue combination chemotherapy. Adjuvant chemotherapy should reduce the intensity of treatment and shorten the therapy time. Fever patients during chemotherapy need to receive differential diagnosis and screening according to national standards. Patients with stable diseases and good general conditions may delay imaging examination. Clinicians should make individual clinical decisions based on the specifics of each patient during epidemic situation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Y H</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal Cancer, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Bejing 100142, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>J</ForeName><Initials>J</Initials></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Wei Chang Wai Ke Za Zhi</MedlineTA><NlmUniqueID>101177990</NlmUniqueID><ISSNLinking>1671-0274</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017024" MajorTopicYN="N">Chemotherapy, Adjuvant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="Y">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText>新型冠状病毒肺炎疫情的爆发给结直肠癌的治疗带来了困难。肿瘤患者作为感染的高危人群，肿瘤病史作为新冠肺炎不良预后的重要因素，都是当下医患双方共同面临的挑战。对于复发转移性结直肠癌患者，低强度的维持治疗是更好的选择，病情变化或恶性度较高的肿瘤患者仍需接受联合化疗。对于根治术后的患者，鉴于辅助化疗获益程度的相对有限，可降低治疗强度并减少治疗时间。面对发热的肿瘤化疗患者，需要对患者的发热原因进行分析，按国家《新型冠状病毒感染的肺炎诊疗方案（试行第六版）》文件规定的流程接受排查。病情稳定、一般状况良好及治疗有效的患者可择期推迟影像学评估的时间。临床医师应根据每例患者的具体情况作出个体化的临床决策。.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chemotherapy</Keyword><Keyword MajorTopicYN="N">Colorectal neoplasms</Keyword><Keyword MajorTopicYN="N">Corona virus disease 2019</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32192297</ArticleId><ArticleId IdType="doi">10.3760/cma.j.cn.441530-20200225-00089</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>République populaire de Chine</li></country></list><tree><noCountry><name sortKey="Li, J" sort="Li, J" uniqKey="Li J" first="J" last="Li">J. Li</name><name sortKey="Shen, L" sort="Shen, L" uniqKey="Shen L" first="L" last="Shen">L. Shen</name></noCountry><country name="République populaire de Chine"><noRegion><name sortKey="Li, Y H" sort="Li, Y H" uniqKey="Li Y" first="Y H" last="Li">Y H Li</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001320 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001320 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:32192297
|texte= [Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:32192297" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a CovidV2
| This area was generated with Dilib version V0.6.33. |  |